Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity (Q48967125)

17 February 2018

title

Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity (English)

1 reference

17 February 2018

0 references

Laske C

1

1 reference

17 February 2018

Oschmann P

2

1 reference

17 February 2018

Tofighi J

3

1 reference

17 February 2018

Kuehne SB

4

1 reference

17 February 2018

Diehl H

5

1 reference

17 February 2018

Bregenzer T

6

1 reference

17 February 2018

Kraus J

7

1 reference

17 February 2018

Bauer R

8

1 reference

17 February 2018

Chatzimanolis N

9

1 reference

17 February 2018

Kern A

10

1 reference

17 February 2018

Traupe H

11

1 reference

17 February 2018

Kaps M

12

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

17 February 2018

Acta Neurologica Scandinavica

published in

1 reference

17 February 2018

volume

103

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

105-113

1 reference

17 February 2018

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Shedding of tumor necrosis factor receptors by activated human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Procedures for comparing samples with multiple endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

1 reference

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103002105.X

7 January 2021

10.1034/J.1600-0404.2001.103002105.X

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018